![Frontiers | Automated Manufacture of Autologous CD19 CAR-T Cells for Treatment of Non-hodgkin Lymphoma Frontiers | Automated Manufacture of Autologous CD19 CAR-T Cells for Treatment of Non-hodgkin Lymphoma](https://www.frontiersin.org/files/Articles/561200/fimmu-11-01941-HTML-r1/image_m/fimmu-11-01941-g001.jpg)
Frontiers | Automated Manufacture of Autologous CD19 CAR-T Cells for Treatment of Non-hodgkin Lymphoma
![Modulation of CD19 promoter activity in cHL and B-NHL cell lines. (A)... | Download Scientific Diagram Modulation of CD19 promoter activity in cHL and B-NHL cell lines. (A)... | Download Scientific Diagram](https://www.researchgate.net/publication/309088415/figure/fig1/AS:726594289147906@1550244986255/Modulation-of-CD19-promoter-activity-in-cHL-and-B-NHL-cell-lines-A-Expression-of-the.png)
Modulation of CD19 promoter activity in cHL and B-NHL cell lines. (A)... | Download Scientific Diagram
![Screening for CD19-specific chimaeric antigen receptors with enhanced signalling via a barcoded library of intracellular domains | Nature Biomedical Engineering Screening for CD19-specific chimaeric antigen receptors with enhanced signalling via a barcoded library of intracellular domains | Nature Biomedical Engineering](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41551-022-00896-0/MediaObjects/41551_2022_896_Fig1_HTML.png)
Screening for CD19-specific chimaeric antigen receptors with enhanced signalling via a barcoded library of intracellular domains | Nature Biomedical Engineering
![Single-Cell Analyses Identify Brain Mural Cells Expressing CD19 as Potential Off-Tumor Targets for CAR-T Immunotherapies - ScienceDirect Single-Cell Analyses Identify Brain Mural Cells Expressing CD19 as Potential Off-Tumor Targets for CAR-T Immunotherapies - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0092867420310138-fx1.jpg)
Single-Cell Analyses Identify Brain Mural Cells Expressing CD19 as Potential Off-Tumor Targets for CAR-T Immunotherapies - ScienceDirect
![CD19: a biomarker for B cell development, lymphoma diagnosis and therapy | Experimental Hematology & Oncology | Full Text CD19: a biomarker for B cell development, lymphoma diagnosis and therapy | Experimental Hematology & Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F2162-3619-1-36/MediaObjects/40164_2012_Article_34_Fig1_HTML.jpg)
CD19: a biomarker for B cell development, lymphoma diagnosis and therapy | Experimental Hematology & Oncology | Full Text
Establishing CD19 B-cell reference control materials for comparable and quantitative cytometric expression analysis | PLOS ONE
![Surface expression of CD19, CD20, CD22, and CD37 in multiple subtypes... | Download Scientific Diagram Surface expression of CD19, CD20, CD22, and CD37 in multiple subtypes... | Download Scientific Diagram](https://www.researchgate.net/publication/332385293/figure/fig1/AS:747042058039298@1555120114748/Surface-expression-of-CD19-CD20-CD22-and-CD37-in-multiple-subtypes-of-B-NHL-Flow.png)
Surface expression of CD19, CD20, CD22, and CD37 in multiple subtypes... | Download Scientific Diagram
![Human T Cells Expressing a CD19 CAR-T Receptor Provide Insights into Mechanisms of Human CD19-Positive β Cell Destruction - ScienceDirect Human T Cells Expressing a CD19 CAR-T Receptor Provide Insights into Mechanisms of Human CD19-Positive β Cell Destruction - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2666379120301233-fx1.jpg)
Human T Cells Expressing a CD19 CAR-T Receptor Provide Insights into Mechanisms of Human CD19-Positive β Cell Destruction - ScienceDirect
![Selective B cell depletion upon intravenous infusion of replication-incompetent anti-CD19 CAR lentivirus: Molecular Therapy - Methods & Clinical Development Selective B cell depletion upon intravenous infusion of replication-incompetent anti-CD19 CAR lentivirus: Molecular Therapy - Methods & Clinical Development](https://www.cell.com/cms/asset/aad63588-3390-40fb-bcce-705353ca9f62/fx1.jpg)
Selective B cell depletion upon intravenous infusion of replication-incompetent anti-CD19 CAR lentivirus: Molecular Therapy - Methods & Clinical Development
![Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors | Nature Reviews Clinical Oncology Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors | Nature Reviews Clinical Oncology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnrclinonc.2013.46/MediaObjects/41571_2013_Article_BFnrclinonc201346_Fig1_HTML.jpg)
Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors | Nature Reviews Clinical Oncology
![CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trial | Nature Medicine CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trial | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-021-01497-1/MediaObjects/41591_2021_1497_Fig1_HTML.png)